Click on image to view larger version.

Figure 4 Platelet Inhibition With Clopidogrel in Diabetic Patients With Elevated Fibrinogen

Subjects with both diabetes mellitus and elevated plasma fibrinogen (375 mg/dl) have significantly lower platelet inhibition with clopidogrel compared with nondiabetic patients or diabetic patients with lower fibrinogen levels. The adjusted platelet inhibition (mean ± SD) with the number of subjects in each group is shown.